Risk and Management of Patients with Cancer and Heart Disease.

Anthracycline Cardiotoxicity Heart failure Risk stratification

Journal

Cardiology and therapy
ISSN: 2193-8261
Titre abrégé: Cardiol Ther
Pays: England
ID NLM: 101634495

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 02 12 2022
accepted: 13 01 2023
medline: 10 2 2023
pubmed: 10 2 2023
entrez: 9 2 2023
Statut: ppublish

Résumé

Cancer and cardiovascular disease are two of the leading causes of global mortality and morbidity. Medical research has generated powerful lifesaving treatments for patients with cancer; however, such treatments may sometimes be at the expense of the patient's myocardium, leading to heart failure. Anti-cancer drugs, including anthracyclines, can result in deleterious cardiac effects, significantly impacting patients' functional capacity, mental well-being, and quality of life. Recognizing this, recent international guidelines and expert papers published recommendations on risk stratification and care delivery, including that of cardio-oncology services. This review will summarize key evidence with a focus on anthracycline therapy, providing clinical guidance for the non-oncology professional caring for a patient with cancer and heart failure.

Identifiants

pubmed: 36757637
doi: 10.1007/s40119-023-00305-w
pii: 10.1007/s40119-023-00305-w
pmc: PMC10209380
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

227-241

Informations de copyright

© 2023. The Author(s).

Références

Eur J Heart Fail. 2005 Jan;7(1):87-93
pubmed: 15642537
Clin Oncol (R Coll Radiol). 2021 Aug;33(8):483-493
pubmed: 33832839
Curr Oncol Rep. 2021 Apr 14;23(6):64
pubmed: 33855620
J Clin Med. 2020 May 07;9(5):
pubmed: 32392882
Lancet Oncol. 2015 Mar;16(3):e123-36
pubmed: 25752563
Cancers (Basel). 2021 Apr 04;13(7):
pubmed: 33916644
Cardiooncology. 2022 Aug 9;8(1):14
pubmed: 35945637
Eur J Heart Fail. 2020 Nov;22(11):1966-1983
pubmed: 33006257
Circulation. 2015 Jun 2;131(22):1981-8
pubmed: 25948538
Circulation. 2022 May 3;145(18):e895-e1032
pubmed: 35363499
JACC CardioOncol. 2019 Sep 24;1(1):41-50
pubmed: 34396161
J Natl Cancer Inst. 2020 Mar 1;112(3):256-265
pubmed: 31161223
Front Cardiovasc Med. 2020 Mar 18;7:26
pubmed: 32258060
Curr Heart Fail Rep. 2022 Feb;19(1):1-6
pubmed: 35000125
J Am Coll Cardiol. 2014 Sep 30;64(13):1310-9
pubmed: 25257631
BMC Cancer. 2019 Jul 3;19(1):653
pubmed: 31269914
Curr Hypertens Rep. 2010 Dec;12(6):404-10
pubmed: 20842465
Heart. 2019 Feb;105(3):210-216
pubmed: 30158136
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt A):2751-68
pubmed: 24703918
J Am Coll Cardiol. 2013 Jan 8;61(1):77-84
pubmed: 23199515
Eur J Heart Fail. 2018 Dec;20(12):1721-1731
pubmed: 30191649
Oncogenesis. 2021 Jan 8;10(1):1
pubmed: 33419963
J Am Coll Cardiol. 2010 Jan 19;55(3):213-20
pubmed: 20117401
J Am Coll Cardiol. 2009 Aug 11;54(7):618-24
pubmed: 19660692
Cochrane Database Syst Rev. 2019 Jun 17;6:CD009955
pubmed: 31204439
J Cardiopulm Rehabil Prev. 2023 Mar 1;43(2):129-134
pubmed: 35940850
JACC CardioOncol. 2021 Mar 16;3(1):1-16
pubmed: 34396303
Breast Cancer. 2017 Nov;24(6):774-782
pubmed: 28434150
Heart. 2015 Dec;101(23):1874-80
pubmed: 26416836
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
JACC Cardiovasc Imaging. 2018 Aug;11(8):1173-1186
pubmed: 30092972
Eur Heart J. 2020 May 7;41(18):1720-1729
pubmed: 32016393
Ann Oncol. 2002 May;13(5):710-5
pubmed: 12075738
Life Sci. 2015 Mar 15;125:9-14
pubmed: 25500304
Br J Sports Med. 2016 Apr;50(7):397-407
pubmed: 26383108
Eur Heart J. 2019 Jun 7;40(22):1756-1763
pubmed: 30085070
J Am Coll Cardiol. 2006 Dec 5;48(11):2258-62
pubmed: 17161256
Am J Cardiol. 2011 May 1;107(9):1375-80
pubmed: 21371685
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
J Natl Cancer Inst. 2012 Sep 5;104(17):1293-305
pubmed: 22949432
Cardiooncology. 2019 Sep 02;5:12
pubmed: 32154018
Eur Heart J. 2022 Jan 31;43(4):280-299
pubmed: 34904661
Am J Cardiol. 2013 Mar 1;111(5):717-22
pubmed: 23228924
Int J Cardiol. 2021 Nov 15;343:139-145
pubmed: 34506825
JACC Cardiovasc Imaging. 2009 Jul;2(7):793-801
pubmed: 19608127
Cancers (Basel). 2020 Apr 28;12(5):
pubmed: 32354131
Am Heart J. 2011 Jul;162(1):64-73
pubmed: 21742091
Eur J Cardiovasc Nurs. 2022 Apr 9;21(3):235-242
pubmed: 34252175
Ann Phys Rehabil Med. 2022 Mar;65(2):101485
pubmed: 33453417
Eur Heart J. 2020 Jan 7;41(2):205-206
pubmed: 31909424
Cardiovasc Res. 2023 May 2;119(3):710-728
pubmed: 35640873
JACC CardioOncol. 2019 Dec 17;1(2):256-272
pubmed: 34396188
Circulation. 2018 Mar 13;137(11):1176-1191
pubmed: 29530893
Scand J Med Sci Sports. 2006 Feb;16 Suppl 1:3-63
pubmed: 16451303
Support Care Cancer. 2017 Aug;25(8):2463-2473
pubmed: 28275898
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
JACC Heart Fail. 2019 Aug;7(8):691-705
pubmed: 31302050
Med Sci Sports Exerc. 2017 Aug;49(8):1599-1605
pubmed: 28350711
Circulation. 2023 Feb 14;147(7):532-545
pubmed: 36342348
PLoS One. 2014 May 06;9(5):e96736
pubmed: 24800827
J Thorac Dis. 2018 Dec;10(Suppl 35):S4391-S4399
pubmed: 30701106
ESC Heart Fail. 2022 Jun;9(3):1666-1676
pubmed: 35362255
Circ J. 2010 Sep;74(9):1779-86
pubmed: 20716834
Curr Opin Support Palliat Care. 2021 Jun 1;15(2):134-140
pubmed: 33605633
Trends Mol Med. 2018 Aug;24(8):709-727
pubmed: 29980479
J Cardiopulm Rehabil Prev. 2019 May;39(3):199-203
pubmed: 31022003
Curr Opin Support Palliat Care. 2015 Dec;9(4):317-24
pubmed: 26509857
J Exerc Sci Fit. 2011;9(1):65-73
pubmed: 21709755
Eur J Heart Fail. 2019 Dec;21(12):1515-1525
pubmed: 31321851
J Am Coll Cardiol. 2000 Aug;36(2):517-22
pubmed: 10933366
Circ Cardiovasc Imaging. 2016 Aug;9(8):
pubmed: 27502058
Eur J Prev Cardiol. 2019 Feb;26(3):305-315
pubmed: 30376366
Eur J Heart Fail. 2020 Nov;22(11):1945-1960
pubmed: 32463967
Eur Heart J. 2022 Nov 1;43(41):4229-4361
pubmed: 36017568
Zdr Varst. 2021 Oct 20;60(4):199-209
pubmed: 34917188
Eur J Heart Fail. 2020 Feb;22(2):350-361
pubmed: 31721381
ESC Heart Fail. 2018 Aug;5(4):620-629
pubmed: 29673122
PLoS One. 2021 Mar 31;16(3):e0249067
pubmed: 33788897
J Clin Oncol. 2017 Mar 10;35(8):878-884
pubmed: 28199174
Clin Chem. 2005 Aug;51(8):1405-10
pubmed: 15932966
Ochsner J. 2016 Fall;16(3):250-6
pubmed: 27660573
BBA Clin. 2016 Jun 15;6:69-75
pubmed: 27413695

Auteurs

Loreena Hill (L)

School of Nursing and Midwifery, Queen's University, 97 Lisburn Road, Belfast, BT9 7BL, UK. l.hill@qub.ac.uk.
College of Nursing and Midwifery, Mohammed Bin Rashid University, Dubai, United Arab Emirates. l.hill@qub.ac.uk.

Bruno Delgado (B)

Cardiology Department, University Hospital Centre of Oporto, Stº António Hospital, Oporto, Portugal.
Institute of Health Sciences, Portuguese Catholic University, Oporto, Portugal.

Ekaterini Lambrinou (E)

Department of Nursing, Cyprus University of Technology, Limassol, Cyprus.

Tara Mannion (T)

Beaumont Hospital, Dublin, Ireland.
School of Nursing, Midwifery and Health Systems, University College Dublin, Dublin, Ireland.

Mark Harbinson (M)

Centre for Public Health, Queen's University Belfast, Belfast, UK.

Claire McCune (C)

School of Medicine Dentistry and Biomedical Sciences, Queen's University, Belfast, UK.
Belfast Health and Social Care Trust, Belfast, UK.

Classifications MeSH